Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/7/2018 |
| Start Date: | August 14, 2017 |
| End Date: | July 31, 2019 |
In the setting of naloxone standing orders, this study will assess if direct outreach with a
web-based "Naloxone Navigator 1.0" to patients prescribed chronic opioid therapy (COT)
changes opioid risk behaviors, increases naloxone uptake, and increases knowledge about
overdose and naloxone
web-based "Naloxone Navigator 1.0" to patients prescribed chronic opioid therapy (COT)
changes opioid risk behaviors, increases naloxone uptake, and increases knowledge about
overdose and naloxone
This is a randomized study of a web-based naloxone educational resource (Naloxone Navigator
1.0) for adults prescribed chronic opioid therapy. This study will be conducted under new
naloxone standing order legislation passed in Colorado. The Naloxone Navigator 1.0 will
provide online training on how to recognize an opioid overdose and respond using naloxone.
There will be two arms: one will receive a link to the Naloxone Navigator 1.0 and the other
will receive usual care (no link). Outcomes will include opioid risk behavior, overdose and
naloxone knowledge, naloxone dispensings, and overdose rates.
1.0) for adults prescribed chronic opioid therapy. This study will be conducted under new
naloxone standing order legislation passed in Colorado. The Naloxone Navigator 1.0 will
provide online training on how to recognize an opioid overdose and respond using naloxone.
There will be two arms: one will receive a link to the Naloxone Navigator 1.0 and the other
will receive usual care (no link). Outcomes will include opioid risk behavior, overdose and
naloxone knowledge, naloxone dispensings, and overdose rates.
Inclusion Criteria:
- 18 years of age or greater prescribed chronic opioid therapy
Exclusion Criteria:
- Non-English speaking, hospice enrollment, do-not-resuscitate order, receipt of
naloxone in the last 12 months, no internet access, not planning to continue to
receive care in the same setting for the next 4 months.
We found this trial at
1
site
Denver, Colorado 80204
Principal Investigator: Ingrid Binswanger, MD
Phone: 303-614-1223
Click here to add this to my saved trials
